SLC2A1 and pancreatic neoplasm: miR-30d acts directly with the transcription factor RUNX1 to reduce the expression of GLUT1 and HK1 genes, and inhibits the genesis of pancreatic tumors by inhibiting aerobic glycolysis [144].